New platform provides deep insights into T cell responses against novel cancer vaccine

BioMed X and the Universitätsmedizin Mannheim (UMM) announced the publication of two manuscripts in the field of cancer immunology in the journal Science Advances. The main objective of the collaboration was to understand the role of specific T cell responses in a patient with an aggressive subtype of diffuse glioma who showed sustained remission after receiving a neoepitope peptide vaccine at the University Hospital Mannheim.